330.27
2.85%
-9.70
After Hours:
330.01
-0.26
-0.08%
Madrigal Pharmaceuticals Inc Stock (MDGL) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.75%
152.04
|
117.18 | 98.53 | 86.45 | 78.34 |
Interest Income/Expense |
3.35%
3.838
|
3.971 | 3.504 | 2.901 | 2.336 |
Operating Income/Loss |
29.75%
-152.04
|
-117.18 | -98.53 | -86.45 | -78.34 |
Income/Loss From Continuing Operations Before Tax |
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
Income/Loss From Continuing Operations After Tax |
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
Net Income/Loss
|
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.22%
20.00
|
19.76 | 18.48 | 18.31 | 18.19 |
Diluted Average Shares |
1.22%
20.00
|
19.76 | 18.48 | 18.31 | 18.19 |
Basic Earnings Per Share |
29.93%
-7.38
|
-5.68 | -5.34 | -4.69 | -4.23 |
Diluted Earnings Per Share |
29.93%
-7.38
|
-5.68 | -5.34 | -4.69 | -4.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):